Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Leukemia, Myeloid, Acute 188Leukemia, Lymphocytic, Chronic, B-Cell 69Myelodysplastic Syndromes 47Recurrence 30Leukemia 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Lymphoma, Mantle-Cell 20Leukemia, Myelomonocytic, Chronic 19Hematologic Neoplasms 14Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13Lymphoma, Non-Hodgkin 13Lymphoma 13Leukemia, Biphenotypic, Acute 13Burkitt Lymphoma 13Lymphoma, B-Cell, Marginal Zone 12Multiple Myeloma 11Lymphoma, Large B-Cell, Diffuse 11Neoplasms 10Waldenstrom Macroglobulinemia 8Myeloproliferative Disorders 8Lymphoma, Follicular 8Lymphoma, B-Cell 7Neoplasm, Residual 6Leukemia, Myeloid 5Blastic Plasmacytoid Dendritic Cell Neoplasm 5Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4GATA2 Deficiency 4Leukemia, Monocytic, Acute 3Immunoglobulin Light-chain Amyloidosis 3

Interventions

Cyclophosphamide 8ibrutinib 5fludarabine phosphate 5fludarabine 5pirtobrutinib 4Mesna 4obinutuzumab 3acalabrutinib 3Mycophenolic Acid 3Melphalan 3venetoclax 2Whole-Body Irradiation 2Tacrolimus 2Rituximab 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Busulfan 2Bone Marrow Transplantation 2ARQ531 2ricolinostat 1idelalisib 1idecabtagene vicleucel 1Vincristine 1Stem Cell Transplantation 1Rabeprazole 1Prednisone 1Leukapheresis 1Itraconazole 1Filgrastim 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, B-Cell × venetoclax × 1 year × Clear all
NCT04608318 2026-04-30

CLL17

German CLL Study Group

Phase 3 Active not recruiting
897 enrolled
LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT03766763 2025-11-26

Preemptive Therapy for High Risk Chronic Lymphoid Leukemia Stage A

French Innovative Leukemia Organisation

Phase 2 Active not recruiting
82 enrolled
LymphoidOther hematologic neoplasm

Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡